Qifeng Yang

Title: Innovations of Qifeng Yang in Ion Channel Screening

Introduction

Qifeng Yang is a notable inventor based in Belle Meade, NJ (US). He has made significant contributions to the field of ion channel research, particularly through his innovative patents. With a total of two patents to his name, Yang's work focuses on high throughput screening assays that address critical needs in the scientific community.

Latest Patents

Yang's latest patents include a high throughput screening assay for the TRPM5 ion channel. This invention addresses the need for assays that can identify compounds specifically modulating the activity of fast-acting ion channels like TRPM5. Current methods are often limited by sensitivity, low throughput, and labor intensity. Yang's claimed methods provide fluorescent assays with an optical readout, enabling rapid results, a high signal-to-noise ratio, ease of use, and potential for automation and miniaturization. Additionally, he has developed a screening assay for inhibitors of TRPA1 activation by lower alkyl phenols. This invention is particularly relevant for screening compounds that inhibit the activation of TRPA1 by thymol, a lower alkyl phenol known for its objectionable taste in medical applications.

Career Highlights

Qifeng Yang is currently associated with Redpoint Bio Corporation, where he continues to advance his research in ion channel modulation. His work has been instrumental in developing assays that enhance the understanding of ion channel behavior and their modulation by various compounds.

Collaborations

Yang collaborates with esteemed colleagues, including Robert Bryant and S Paul Lee, who contribute to his research endeavors and innovations in the field.

Conclusion

Qifeng Yang's contributions to ion channel research through his innovative patents highlight his role as a significant inventor in the scientific community. His work not only addresses existing challenges but also paves the way for future advancements in the field.